Clinical eligibility
History, medications and relevant findings guide evaluation of medical weight-management options.
Secondary care / Metabolic healthBeyond the scale.
Beyond the scale.
A clinical view.
Medical weight management brings medication suitability, metabolic markers and sustainable habits into one assessment. Hormone findings add context, not an automatic TRT prescription.
A considered approach01 02 03
Metabolic health belongs in the picture.
A wider assessment
Glucose, lipids, hormone findings and body-composition context may inform care when clinically relevant.
Ongoing review
Provider follow-up considers tolerability, response, nutrition, protein intake and activity—not scale weight alone.
Care option
Options. Not a combination.
Tirzepatide and semaglutide are alternatives. The exact medication, formulation, indication and cost are reviewed individually.
Tirzepatide and semaglutide are alternatives considered according to their own indications—not a routine combination. FDA-approved products and compounded preparations are not interchangeable approval claims. Compounded preparations are not FDA-approved. Product imagery shows a format, not verified dispensed packaging; formulations and availability vary.
Discuss at a consultationThe purpose of the planMeaningful goals.
01 02 03
Meaningful goals.
Thoughtful care.
Weight-management goals
A plan that can combine nutrition, activity and medication when clinically appropriate—not medication in isolation.
Strength & everyday movement
Training, nutrition and body-composition goals can inform care without assuming a particular treatment outcome.
Support that continues
Follow-up gives the provider a chance to review progress, tolerability and whether the plan still fits.
These are care goals, not promised results. Treatment suitability, benefits, risks and response vary by individual.
A closer look
Options with context.
Tirzepatide
A dual GIP/GLP-1 receptor agonist. FDA-approved Zepbound and Mounjaro have different indications; eligibility, product choice and risks require clinical review. Manufacturer trial results do not establish compounded-product equivalence.
Semaglutide
A GLP-1 receptor agonist. The indication and approval belong to a specific product; formulation, eligibility and risks matter. No medication is suitable for every patient.
The hormone connection
Weight management can improve obesity-related reductions in testosterone in some men. That relationship supports coordinated evaluation, not a guaranteed testosterone response or automatic combined therapy.
Costs, stated clearlyA consultation.
A consultation.
A separate care decision.
Self-pay. No insurance billing. HSA/FSA eligibility depends on the individual plan. The clinic confirms the complete cost before care begins.
View all pricingThe program: prescribed GLP-1 therapy, monthly provider visit, dose and plan review, and protein/training guidance. Price depends on medication and dose. The $49 consultation, testing and additional therapies are separate.
Book NowBefore a conversation
A few clear answers.
Clinical context matters. These answers explain the process, not an individual recommendation.
Is medication included in the starting price?
The current source describes prescribed GLP-1 therapy within a program starting at $249 per month, depending on medication and dose. Consultation, testing and additional therapies are separate; the clinic confirms the individual plan and total cost.
Are peptides or TRT automatically added?
No. Each therapy requires a separate clinical indication and risk–benefit decision. Weight management alone, another pathway or no medication may be appropriate.
Are study percentages individual predictions?
No. Published tirzepatide trial values are group means for a defined study population and manufacturer product. They are not clinic results, individual predictions or claims about compounded formulations.
Separate questions. Connected evaluation.
Patients notice the difference.
“For the first time, I felt really heard about my concerns.”
“I felt truly helped, educated and properly prepared for my future health journey.”
“It’s not one-size-fits-all, it’s catered to you.”
Excerpts from Google reviews. Individual results vary.
Let’s talk
Start with a conversation.
Houston clinic. Texas telehealth.